JF
AUTL icon

Jump Financial’s Autolus Therapeutics AUTL Stock Holding History

Jump Financial’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,396
Closed -$170K – 1588
2024
Q4 		$170K Buy
+72,396
New +$245K ﹤0.01% 1509
2024
Q3 		– Sell
-212,294
Closed -$739K – 1639
2024
Q2 		$739K Buy
212,294
+186,794
+733% +$806K 0.01% 952
2024
Q1 		$163K Sell
25,500
-128,664
-83% -$803K ﹤0.01% 1735
2023
Q4 		$993K Buy
+154,164
New +$588K 0.03% 727
2021
Q4 		– Sell
-65,900
Closed -$432K – 1373
2021
Q3 		$432K Buy
65,900
+18,645
+39% +$118K 0.03% 529
2021
Q2 		$314K Buy
47,255
+27,460
+139% +$170K 0.03% 655
2021
Q1 		$113K Buy
+19,795
New +$147K 0.01% 822

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jump Financial's AUTL Position: Q1 2025 in Review

Jump Financial sold out of Autolus Therapeutics (AUTL) in Q1 2025, closing a stake of 72,396 shares — an estimated $170K sold.

Jump Financial first reported a position in AUTL in Q1 2021 and held it in 7 quarters. The position peaked at $993K in Q4 2023. 95 funds tracked by Wall St. Rank hold AUTL as of Q1 2025.

  • Jump Financial reported no remaining Autolus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 72,396 Autolus Therapeutics shares in Q1 2025, an estimated $170K.
  • Jump Financial first reported a position in Autolus Therapeutics in Q1 2021 and held it in 7 quarters.
  • Jump Financial's Autolus Therapeutics position peaked at $993K in Q4 2023.
  • 95 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.